01—Abstract
Summary
Summary of the 8-K filed June 17, 2025. Cited figures are marked; the original filing is the authoritative source.
MetLife Inc. (MET) has announced the issuance of ¥87.84 billion (approximately $790 milliona USD as of June 2025, based on typical exchange rates) in yen-denominated senior notes through a private placement.
This offering consists of six tranches with varying maturities ranging from 2032 to 2055 and coupon rates between 2.14%b and 3.62%. The proceeds are earmarked for refinancing existing debt, specifically ¥25.2 billion of senior notes maturing in 2026, and for general corporate purposes. This transaction diversifies MetLife's funding sources and potentially extends its debt maturity profile.
The issuance in a foreign currency indicates a strategic move to manage currency exposures or access international capital markets. While the notes are not registered under the Securities Act, they were offered in reliance on an exemption for private placements, a common practice for large corporate debt issuances. Investors should note that these are senior unsecured obligations of MetLife, Inc.
02—Key points
Key Highlights
- MetLife issued ¥87.84 billion ($790 million USD equivalent) in yen-denominated senior notes.
- The issuance is comprised of six tranches with maturities from 2032 to 2055.
- Interest rates on the notes range from 2.14% to 3.62%, payable semiannually.
- Proceeds will be used to refinance ¥25.2 billion of maturing senior notes and for general corporate purposes.
- The notes were offered through a private placement under Section 4(a)(2) of the Securities Act, meaning they are not registered with the SEC.
- The transaction diversifies MetLife's debt structure and potentially extends its maturity profile.
- The notes represent direct, senior unsecured obligations of MetLife, Inc.
03—Questions
Frequently Asked Questions
What is the total principal amount of the new notes issued by MetLife?
MetLife issued a total principal amount of ¥87,840,000,000 (approximately $790 million USD equivalent) in yen-denominated senior notes.
How will MetLife use the proceeds from this note issuance?
The proceeds will be used to refinance ¥25,200,000,000 of MetLife's 0.495% Senior Notes due 2026 and for general corporate purposes.
Are these notes publicly traded?
No, these notes were offered and sold in a private placement and have not been registered under the Securities Act of 1933. They are typically held by institutional investors and are not publicly traded.
What are the maturity dates and interest rates for these notes?
The notes have various maturities ranging from June 17, 2032, to June 17, 2055, with annual interest rates ranging from 2.14% to 3.62%.
04—Continue